S2Medical AB — Investor Relations & Filings

S2Medical AB is a biomedical technology company that develops solutions for wound healing, infection control, and cosmeceuticals. The company utilizes biomaterials, antimicrobial peptides (AMPs), and regenerative medicine to create its products. Key technologies include IvaQ, a portable, single-use negative pressure therapy system for managing deep wounds and surgical incisions, and ADMERCIN, a platform designed to combat multi-resistant bacteria by enhancing the efficacy of antibiotics. S2Medical also developed the Epiprotect wound healing technology and continues to be involved in its production following its acquisition by another firm. The company's research and development focuses on creating advanced treatments for wound care and skin restoration.